Synergistic effects of trastuzumab and gambogic acid on MDA-MB-453 breast cancer cell line
Trastuzumab is one of the most commonly used monoclonal antibodies in the treatment of breast cancer. It is effective because it binds to the HER2 receptor and inhibits the signaling pathways for proliferation and metastasis. However, intrinsic or acquired resistance resulting from the various signa...
Saved in:
Main Authors: | Abdullah Alpkan (Author), Murat Cankaya (Author) |
---|---|
Format: | Book |
Published: |
Polskie Towarzystwo Farmaceutyczne,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines
by: Zou Zhengyun, et al.
Published: (2012) -
Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231
by: Tinghua Xu, et al.
Published: (2020) -
BETULINIC ACID WAS MORE CYTOTOXIC TOWARDS THE HUMAN BREAST CANCER CELL LINE MDA-MB-231 THAN THE HUMAN PROMYELOCYTIC LEUKAEMIA CELL LINE HL-60
by: LATIFAH SAIFUL YAZAN, et al.
Published: (2009) -
In vitro investigation of cytotoxic and antioxidative activities of Ardisia crispa against breast cancer cell lines, MCF-7 and MDA-MB-231
by: Muhammad Luqman Nordin, et al.
Published: (2018) -
The selective anti-proliferative and pro-apoptotic effect of A. cherimola on MDA-MB-231 breast cancer cell line
by: Maria Younes, et al.
Published: (2020)